User:Mr. Ibrahem/Calaspargase pegol

Calaspargase pegol, sold under the brand name Asparlas, is a medication used to treat acute lymphoblastic leukemia (ALL). It is used with other medications in those aged 1 month to 21 years. It is given by injection into a vein.

Common side effects include liver problems, pancreatitis, and abnormal blood clotting. Other side effects may include allergic reactions, blood clots, and bleeding. Use in pregnancy may harm the baby. It is made by attaching asparaginase to monomethoxy polyethylene glycol (mPEG).

Calaspargase pegol was approved for medical use in the United States in 2018. In the United States a 3,750 unit vial costs about 25,400 USD as of 2021. It is partly made by E. coli.